Levamisole Hydrochloride

Spécifications

16595-80-5Numéro CAS

240-654-6Numéro CE

(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochlorideNom IUPAC

C11H13ClN2SFormule chimique

240.75 g/molMasse molaire

Levamisole hydrochloride; 16595-80-5; Levamisole HCl; Ergamisol; Ascaridil; Tramisol; Decaris; Levasole; Solaskil; NSC-177023; Spartakon l; L-narpenol; R 12,564; DTXSID7047518; L-Tetramisole hydrochloride; R 12564; Tetramisole hydrochloride, (s)-; Levamisoli hydrochloridum; DL9055K809; Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (S)-; DTXCID5027518; R 12654; R-12564; NSC177023; Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (6S)-; Ergamisole; Immunol; Trimisol; LevaMed; Tramisol Gel; Ripercol L; PROHIBIT; Cloridrato de Levamizol; RefChem:5942; Hydrochloride, Levamisole; LevaMed Soluble Pig Wormer; Levasole Soluble Pig Wormer; Levasole Cattle Wormer Bolus; LevaMed Soluble Drench Powder; Prohibit Soluble Drench Powder; Ripercol L Soluble Drench Powder; ICI-59623; RP-20605; Ripercol L Bolus, Tramisol Cattle Wormer Bolus; Ripercol L, Tramisol Soluble Drench Powder for Sheep; Ripercol L Wormer Oblets, Tramisol Sheep Wormer Oblets; Levasole Sheep Wormer Bolus, Tramisole Sheep Wormer Oblets Tablets; (S)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole Monohydrochloride; 240-654-6; Levamisole Soluble Drench Powder, Levasole, Levasole Soluble Drench Powder, Tramisol Soluble Drench Powder; (S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride; Levamisol hydrochloride; Tramisole; Niratic hydrochloride; Stimamizol hydrochloride; Niratic-puron hydrochloride; R-12,564; (-)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole monohydrochloride; MFCD00012675; Dekaris; Levacide; Levadin; Nemicide; Meglum; Nilverm forte; Worm-chek; (6S)-6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole hydrochloride; Ripercol-L; Citarin L; Levomysol hydrochloride; Levamisole (hydrochloride); (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride; KW 2LE-T; SMR001230807; KW-2-LE-T; Levamisole hydrochloride [USAN]; Levamisole Hydrochloride (1.0 mg/mL in Methanol); SR-01000075969; EINECS 240-654-6; 74191-78-9; (-)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole Hydrochloride; UNII-DL9055K809; LEV hydrochloride; Ergamisol (TN); NCGC00094446-03; Prestwick_294; Levamisole hydrochloride [USAN:USP]; Levamisole HCl(Ergamisol); Levamisole hydrochloride RS; 16595-80-5 (HCL); L-(-)-2,3,5,6-Tetrahydro-6-phenyl-imidazo(2,1-b)thiazole hydrochloride; Ergamisol (TN) (Janssen); CAS-16595-80-5; Levamisole hydrochloride CRS; CHEMBL1770; SCHEMBL19226; BMK1-H6; Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride; MLS002153440; MLS002222198; MLS002695941; orb134393; SPECTRUM1503245; CHEBI:6433; Levamisole hydrochloride (USP); MSK5587A; orb3139781; GLXC-07877; HMS1568F05; HMS1922M11; MSK5587A-100M; Levamisole Hydrochloride (Ergamisol); MSK5587A-1000M; Tox21_111282; Tox21_500690; CCG-40301; EBC-06511; HY-13666R; LEVAMISOLE HYDROCHLORIDE [MI]; s1939; Levamisole HCl - Bio-X trade mark; LEVAMISOLE HYDROCHLORIDE [JAN]; AKOS015951350; Levamisole (hydrochloride) (Standard); Tox21_111282_1; FL29670; KW-2299; LP00690; Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)-; Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, L-(-)-; LEVAMISOLE HYDROCHLORIDE [MART.]; LEVAMISOLE HYDROCHLORIDE [USP-RS]; LEVAMISOLE HYDROCHLORIDE [WHO-DD]; LEVAMISOLE HYDROCHLORIDE [WHO-IP]; NCGC00094046-01; NCGC00261375-01; NCGC00263461-01; AC-23973; AS-13370; BL166245; HY-13666; EU-0100690; L0231; L1682; LEVAMISOLE HYDROCHLORIDE [GREEN BOOK]; NS00076395; (-)-Tetramisole hydrochloride, >=99% (GC); LEVAMISOLE HYDROCHLORIDE [ORANGE BOOK]; C07906; D00750; D78137; EN300-122366; L 9756; Levamisole Hydrochloride (1 mg/mL in Methanol); LEVAMISOLE HYDROCHLORIDE [EP MONOGRAPH]; LEVAMISOLE HYDROCHLORIDE [USP MONOGRAPH]; LEVAMISOLI HYDROCHLORIDUM [WHO-IP LATIN]; F094384; Levamisole hydrochloride for system suitability CRS; Levamisol hydrochloride 100 |Ig/mL in Acetonitrile; SR-01000075969-1; SR-01000075969-6; Levamisol hydrochloride 100 microg/mL in Acetonitrile; Q27107205; Levamisole hydrochloride Solution in Methanol, 100ug/mL; Z1550648764; Levamisol hydrochloride, VETRANAL(TM), analytical standard; Levamisole hydrochloride Solution in Methanol, 1000ug/mL; Levamisole Hydrochloride 1.0 mg/ml in Methanol (as free base); Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)-; Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (S)-; (-)-2,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole monohydrochloride; (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole;hydrochloride; (S)-(-)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride; (S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazolehydrochloride; Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, L-(-)-; L(-)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole hydrochloride; Levamisole Hydrochloride Working Standard (Secondary Reference Standard); Levamisole hydrochloride, European Pharmacopoeia (EP) Reference Standard; (6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole--hydrogen chloride (1/1); Levamisole Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Levamisole hydrochloride, United States Pharmacopeia (USP) Reference Standard; Levamisole hydrochloride for system suitability, European Pharmacopoeia (EP) Reference StandardSynonymes